ALK and anaplastic large cell lymphoma: This CD30-positive, anaplastic lymphoma kinase (ALK)-negative malignancy has been increasingly recognized, with the Food and Drug Administration (FDA) reporting a total of 1380 cases of BIA-ALCL with 64 known deaths as of 8 July 2025 [2].